Status:
COMPLETED
Evaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community Setting
Lead Sponsor:
Fox Chase Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Prostate Cancer
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study was designed to provide a preliminary evaluation of the efficacy and usability of the 2004 revised version of the booklet, Facing Forward , Life After Cancer Treatment, (hereafter,Facing Fo...
Detailed Description
This study was designed to provide a preliminary evaluation of the efficacy and usability of the 2004 revised version of the booklet, Facing Forward, Life After Cancer Treatment (hereafter,Facing Forw...
Eligibility Criteria
Inclusion
- current age at or above 18 years;
- breast, colorectal, prostate, and/or thoracic cancer diagnosis,stage I, II, IIIa;
- approaching or attending the last treatment appointment of chemotherapy and or radiation therapy for the cancer diagnosis
- English speaking (able to read English at an 8th grade level);
- have a mailing address;
- have residential phone service;
- able to give informed consent.
Exclusion
- patients who have received surgery only with no adjuvant therapy;
- second primary cancer or recurrent disease;
- patients receiving brachytherapy only
Key Trial Info
Start Date :
February 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2009
Estimated Enrollment :
340 Patients enrolled
Trial Details
Trial ID
NCT01440855
Start Date
February 1 2005
End Date
October 1 2009
Last Update
October 4 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States, 19111